Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT04303988

Recruiting

A Phase II Study of Triple-negative Breast Cancer Brain Metastases.

Breast Cancer
NCT04250064

Recruiting

A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma (LoBULarDIPG)

DIPG
NCT02507336

Completed

Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165

Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma
NCT04298372

Completed

Frontline Lenalidomide for AL Amyloidosis Involving Myocardium

Amyloidosis Cardiac
NCT06365398

Completed

Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy (SELECT)

Cerebral Angiography | Heparinization
NCT02399410

Completed

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis

Colorectal Neoplasms
NCT04313790

Completed

Assessment of the Anti-inflammatory Effect of Heparin Infusion Versus Subcutaneous Injection in Septic Patients

Sepsis | Critical Illness
NCT04212793

Completed

Detection of PitNET Tissue During TSS Using Bevacizumab-800CW (DEPARTURE)

Pituitary Adenoma | Pituitary Tumor | Pituitary Macroadenoma
NCT05005455

Completed

Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects

Healthy Male Subjects
NCT01468831

Completed

Minocycline to Treat Branch Retinal Vein Occlusion

Retinal Vein Occlusion
NCT00591734

Completed

RAD001 Plus Bevacizumab in Metastatic Melanoma

Metastatic Melanoma
NCT00000790

Completed

Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection

HIV Infections | Stomatitis, Aphthous
NCT02743078

Terminated

Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma

Glioma | Glioblastoma | Gliosarcoma
NCT04525326

Unknown

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

Colorectal Cancer | Liver Metastases
NCT00662831

Completed

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (FEENICS)

Diabetic Foot Ulcer
NCT01669707

Unknown

Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer
NCT02192541

Terminated

Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas

Neoplasms
NCT01084993

Unknown

EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding (EASY-B2B)

Coronary Artery Disease
NCT02866903

Unknown

Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis (IPOXA)

Peritoneal Carcinosis
NCT01274637

Completed

PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot (PROSPER)

Venous Thromboembolism | Postpartum
NCT00651482

Terminated

Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)

Kidney Neoplasms | Kidney (Renal Cell) Cancer
NCT02036723

Withdrawn

Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration (GALATIR)

Wet Age-related Macular Degeneration
NCT00913913

Terminated

Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

Metastatic Renal Cell Carcinoma
NCT00609869

Completed

Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab

Mantle Cell Lymphoma | Lymphocytic Leukemia
NCT02295930

Completed

Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient (MACBETH)

Metastatic Colorectal Cancer
NCT01445899

Completed

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) (MATISSE)

Diabetic Retinopathy | Diabetic Macular Edema | Choroidal Neovascularization
NCT00657150

Completed

Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty

Venous Thromboembolism
NCT01225822

Completed

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

Venous Thromboembolism
NCT00006005

Completed

Thalidomide in Treating Patients With Gynecologic Sarcomas

Sarcoma | Endometrial Cancer
NCT00003850

Completed

Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Head and Neck Cancer
NCT00379353

Completed

The Effects of Thalidomide on Symptom Clusters

Advanced Cancers
NCT01513200

Completed

Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia

Healthy Volunteers
NCT00435487

Terminated

Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome

Myocardial Infarction | Angina, Unstable
NCT00455871

Unknown

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Age-Related Macular Degeneration
NCT07179250

Not yet recruiting

Effect of Breathing Training on Symptoms of Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease (GERD) | Diaphragmatic Breathing | Breath Exercise | Incentive Spirometer
NCT06501040

Recruiting

Increasing Knowledge and Interest in Cancer Clinical Trials

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm
NCT05805306

Completed

Entre Herman@s: Promoting Health Among Latino MSM

HIV Infections
NCT06605924

Completed

Oral Nicotine Pouch Marketing Features Influence on Perceptions

Tobacco Use
NCT00190788

Completed

Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion

Sepsis | Hypotension
NCT05904028

Recruiting

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD (AO)

Neovascular Age-related Macular Degeneration
NCT03734614

Recruiting

Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma

Aspirin as Adjuvant Therapy in Patients With Surgically Treated High Risk Renal Cell Carcinoma
NCT00033254

Completed

Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases

Tumors Metastatic to Brain
NCT01898130

Completed

Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer
NCT03845049

Terminated

Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1 (TELeMAC)

Macular Telangiectasia
NCT05329155

Completed

Early Administration of Heparin At FMC for PPCI of STEMI Patients (HELP-PCI)

STEMI | Primary PCI
NCT00407654

Completed

VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer
NCT05126966

Withdrawn

A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration (Diagrid)

Neovascular Age-Related Macular Degeneration
NCT05867030

Withdrawn

Parsaclisib in Patients With Relapsed or Refractory Follicular Lymphoma

Follicular Lymphoma
NCT00375609

Completed

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

Thromboembolism
NCT04274335

Completed

Pharmacokinetics and Pharmacodynamics of Tranexamic Acid in Women Having Caesarean Section Birth [WOMAN-PharmacoTXA]

Pregnancy, High Risk

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations